Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)'s share was trading at $84.03 as of Jan 29^th. NVO’s trailing and forward P/E were 28.32 and 21.88 respectively according to Yahoo Finance.

[caption id="attachment_518884" align="aligncenter" width="750"] Copyright: Kurhan / 123RF Stock Photo[/caption]

Novo Nordisk (NVO) has been experiencing a challenging period, primarily due to regulatory pressures and mixed trial results. Recently, the Centers for...